Pages that link to "Q36959997"
Jump to navigation
Jump to search
The following pages link to Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors (Q36959997):
Displaying 50 items.
- Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA (Q21559495) (← links)
- The role of epigenetics in the pathology of diabetic complications (Q24609124) (← links)
- Epigenetics: a molecular link between environmental factors and type 2 diabetes (Q24652830) (← links)
- Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy (Q26744442) (← links)
- Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules (Q26825664) (← links)
- Nutrition, Epigenetics, and Metabolic Syndrome (Q26829684) (← links)
- Human genetics of diabetic vascular complications (Q27000709) (← links)
- Which stem cells to repair the endocrine pancreas? (Q27004818) (← links)
- Translational implications of the β-cell epigenome in diabetes mellitus (Q27009451) (← links)
- Natural history of β-cell adaptation and failure in type 2 diabetes (Q28082002) (← links)
- Epigenetic Regulation of Islet Development and Regeneration (Q28109395) (← links)
- Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children (Q28575131) (← links)
- Small-molecule inhibitors of the cystic fibrosis transmembrane conductance regulator increase pancreatic endocrine cell development in rat and mouse (Q28583013) (← links)
- Child health, developmental plasticity, and epigenetic programming (Q30466805) (← links)
- Epigenomic plasticity enables human pancreatic α to β cell reprogramming. (Q30536573) (← links)
- Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma (Q33700895) (← links)
- Revealing transcription factors during human pancreatic β cell development (Q34206308) (← links)
- OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas. (Q34732784) (← links)
- Potential of epigenetic therapies in non-cancerous conditions (Q34742578) (← links)
- A small-molecule inducer of PDX1 expression identified by high-throughput screening. (Q35056869) (← links)
- A systems view of epigenetic networks regulating pancreas development and β-cell function (Q35118749) (← links)
- Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9 (Q35405305) (← links)
- Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells. (Q35887221) (← links)
- Organogenesis and functional genomics of the endocrine pancreas (Q35923237) (← links)
- Deconstructing pancreas developmental biology (Q36009271) (← links)
- Chemical methods to induce Beta-cell proliferation (Q36090704) (← links)
- Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells (Q36145871) (← links)
- Activation of the transcription factor carbohydrate-responsive element-binding protein by glucose leads to increased pancreatic beta cell differentiation in rats (Q36208159) (← links)
- Valproic Acid Increases the Hepatic Differentiation Potential of Salivary Gland Cells (Q36475172) (← links)
- Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs (Q36509087) (← links)
- Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules (Q36576142) (← links)
- Reprogramming adult human dermal fibroblasts to islet-like cells by epigenetic modification coupled to transcription factor modulation (Q37139609) (← links)
- Targeting histone deacetylases for the treatment of disease (Q37296159) (← links)
- Expression levels of histone deacetylases determine the cell fate of hematopoietic progenitors. (Q37431856) (← links)
- The hexosamine biosynthesis pathway is essential for pancreatic beta cell development. (Q37433428) (← links)
- Molecular and cellular regulation of pancreatic acinar cell function (Q37538446) (← links)
- Oxygen: a master regulator of pancreatic development? (Q37543521) (← links)
- Conditional ablation of HDAC3 in islet beta cells results in glucose intolerance and enhanced susceptibility to STZ-induced diabetes (Q37628891) (← links)
- Transcriptional Control of Acinar Development and Homeostasis (Q37809241) (← links)
- Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus (Q37832964) (← links)
- Pancreas organogenesis: From bud to plexus to gland (Q37845287) (← links)
- Cell-based therapy of diabetes: What are the new sources of beta cells? (Q37903536) (← links)
- Epigenetics and diabetes treatment: an unrealized promise? (Q37994385) (← links)
- Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming (Q38006956) (← links)
- Lineage determinants in early endocrine development (Q38021286) (← links)
- Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes (Q38086766) (← links)
- Epigenetic regulation of pancreatic islets (Q38125919) (← links)
- Notch signaling in the pancreas: patterning and cell fate specification (Q38135365) (← links)
- Transcriptional control of mammalian pancreas organogenesis (Q38162099) (← links)
- Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature (Q38166178) (← links)